Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIronPPH
NCT04505514Phase 4Unknown
- Sponsor
- Universiti Malaya
- Start
- Aug 2020
- Primary completion
- Oct 2022
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ferric derisomaltose in postpartum anemia (2 arms), sponsored by Universiti Malaya. Primary endpoints: Hemoglobin concentration at 6 weeks, Serum iron concentration at 6 weeks and 1 more. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
postpartum anemia
Beyond the preview
Go deeper on NCT04505514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505514.